Neural Noise

INBRAIN Neuroelectronics

2 min read

  • INBRAIN Neuroelectronics announced a collaboration with Microsoft to advance agentic AI for precision neurology and BCI therapeutics.1
  • The partnership signals an industry move toward AI-driven closed-loop neurotherapeutics, with an implementation path of 12–24 months.1 1

Weekly enrichment (2026-07-20)

  • INBRAIN Neuroelectronics, a Barcelona-based brain-computer interface therapeutics (BCI-Tx) company spun out of leading nanoscience institutes, announced the Microsoft collaboration on November 9, 2025 to explore agentic AI for real-time precision neurology.2 3
  • The company’s platform is built on a high-density graphene neural interface arranged in a hexagonal lattice, described as ultra-thin and highly conductive, enabling micrometric decoding and modulation of neural circuits.3 4
  • The collaboration runs on Microsoft’s Azure AI infrastructure, specifically using time-series large language models (LLMs) and data analytics so the neural platform can continuously learn from and adapt to individual patient signals.2 4
  • Stated therapeutic targets are closed-loop, personalized interventions for Parkinson’s disease, epilepsy, and psychiatric or memory disorders, plus stroke rehabilitation.2 3
  • INBRAIN’s implant has received U.S. FDA Breakthrough Device designation for Parkinson’s disease, and the company had previously closed a Series B financing round.4
  • The agentic AI framing means AI systems act with autonomy to monitor neural time-series data, make decisions, and trigger therapeutic stimulation adjustments without a human in the loop for every step.4
  • CEO and co-founder Carolina Aguilar framed the goal as “the most intelligent, autonomous, and personalized interface between the nervous system and AI”; Microsoft’s Clare Barclay (President, Enterprise and Industry, EMEA) called it “the next frontier of AI.”2 3
  • INBRAIN is extending beyond the CNS via its subsidiary INNERVIA Bioelectronics and a collaboration with Merck KGaA, targeting peripheral nerve and systemic-disease applications.2
  • Financial terms, patient enrollment numbers, and a firm clinical timeline were not reported in the announcement coverage.2 4

Footnotes

  1. https://news.google.com/rss/articles/CBMisgJBVV95cUxPX3JSdGpaU183MzdqQld2WDdCMTVEYTJUZmxkM3lYNXRmVi1mLXI4TXF4UjB2eTc5RzZMcE5oSWxhcklOM1hNNjNqTWhHOVRjUlJZaWwyYVZQLU5GRmJ5SFNHZnB4d0tlZnUwMXl6UFNkNHZHZU5zM1Zqc1JWUS1UN25SQ0U2S19hbkZmb09vQXdaejhOY000Sk04RG5BN1BaQWN5MkpWTGVrVThCYkN4c2pPWmV1Q3hYOUF3WEFyOGtnX3hDRUQxdDRSaDF2Ui1iTUdZbDRPRHQzSFR3Vmx2cjhxWlZXMWtlUExxV3ZsVG9iVFNrX0ViQ1ZtVHpWUEw4YWJzN1lOQzlORzY4NkVqdnJkZUJDZzd4U2EwWjJyVGhyRFhvR0ctaW9TLWx5SWVlM2c?oc=5 ↩ ↩2 ↩3

  2. https://www.businesswire.com/news/home/20251109800738/en/INBRAIN-Neuroelectronics-Announces-Collaboration-with-Microsoft-to-Advance-Agentic-AI-for-Precision-Neurology-and-Brain-Computer-Interface-Therapeutics ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  3. https://www.medicaldevice-network.com/news/inbrain-collaborates-with-microsoft-to-advance-bci-with-agentic-ai/ ↩ ↩2 ↩3 ↩4

  4. https://thedebrief.org/microsoft-and-inbrain-neuroelectronics-partner-to-advance-ai-driven-brain-computer-interface-therapeutics/ ↩ ↩2 ↩3 ↩4 ↩5

Graph View